TipRanks
Faeth Therapeutics (FTH)
NASDAQ:FTH
US Market
FTH
Faeth Therapeutics
RESEARCH TOOLSreports
Want to see FTH full AI Analyst Report?

Faeth Therapeutics (FTH) Income Statement

254 Followers

Faeth Therapeutics Income Statement

Last quarter (Q2 2026), Faeth Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Faeth Therapeutics's net income was $-16.01M. See Faeth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -551.00K$ -571.00K$ -1.81M$ -685.00K
Operating Expenses
$ 22.29M$ 31.11M$ 36.49M$ 47.31M$ 36.80M
Depreciation and Amortization
$ 139.00K$ 551.00K$ 3.68M$ 1.81M$ 685.00K
EBITDA
$ -20.91M$ -29.52M$ -33.39M$ -46.56M$ -35.44M
Operating Income
$ -22.29M$ -31.66M$ -37.06M$ -49.12M$ -37.48M
Other Income/Expenses
$ 1.20M$ 1.51M$ 2.96M$ 532.00K$ 688.00K
Pretax Income
$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Net Income
$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Per Share Metrics
Basic EPS
$ -16.72$ -24.01$ -24.40$ -31.65$ -26.56
Diluted EPS
$ -16.72$ -24.01$ -24.40$ -31.65$ -26.56
Weighted Average Shares Outstanding
 1.26M 1.26M 1.40M 1.54M 1.39M
Weighted Average Shares Outstanding (Diluted)
 1.26M 1.26M 1.40M 1.54M 1.39M
Currency in USD

Faeth Therapeutics Earnings and Revenue History